FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...